SMALL MOLECULE PREFILLED SYRINGES MARKET ANALYSIS

Small Molecule Prefilled Syringes Market, By Type (Single-chamber Prefilled Syringes, Dual-chamber Prefilled Syringes, and Customized Prefilled Syringes), By Material Type (Glass and Plastic & Polymer), By Application (Diabetes, Cancer, Opthalmology, Anaphylaxis, Rheumatoid Arthritis and Others (Thrombosis, etc.)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Sep 2023
Code : CMI1629
Pages :276
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Global Small Molecule Prefilled Syringes Market- Regional Analysis

Among region, North America is estimated to hold a dominant position in the global small molecule prefilled syringes market over the forecast period. North America is estimated to hold 33.5 % of the market share in 2023. North America small molecule prefilled syringes market is expected to witness significant growth in thenear future due toincreasing product approvals by the regulatory authorities. For instance, in February 2022, Takeda Pharmaceutical Company Limited, a pharmaceutical company, announced that it had received approval by the U.S. Food and Drug Administration (FDA) for its single-dose prefilled injection syringe (PFS) named TAKHZYRO (lanadelumab-flyo) for the prevention of attacks of hereditary angioedema (HAE) in adult and pediatric patients of age 12 years and older. The PFS is ready-to-use and requires fewer preparation steps than the current TAKHZYRO vial injection, while reducing supplies and waste.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa